These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30878206)

  • 1. Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.
    Deneau M; Perito E; Ricciuto A; Gupta N; Kamath BM; Palle S; Vitola B; Smolka V; Ferrari F; Amir AZ; Miloh T; Papadopoulou A; Mohan P; Mack C; Kolho KL; Iorio R; El-Matary W; Venkat V; Chan A; Saubermann L; Valentino PL; Shah U; Miethke A; Lin H; Jensen MK
    J Pediatr; 2019 Jun; 209():92-96.e1. PubMed ID: 30878206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children.
    Gilger MA; Gann ME; Opekun AR; Gleason WA
    J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):136-41. PubMed ID: 10941964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.
    Deneau MR; Mack C; Mogul D; Perito ER; Valentino PL; Amir AZ; DiGuglielmo M; Draijer LG; El-Matary W; Furuya KN; Gupta N; Hochberg JT; Horslen S; Jensen MK; Jonas MM; Kerkar N; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Martinez M; Miethke A; Miloh T; Mohammad S; Ovchinsky N; Rao G; Ricciuto A; Sathya P; Schwarz KB; Shah U; Singh R; Vitola B; Zizzo A; Guthery SL
    Hepatology; 2021 Mar; 73(3):1061-1073. PubMed ID: 32946600
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
    Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH
    Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine.
    Kozaiwa K; Tajiri H; Sawada A; Tada K; Etani Y; Miki K; Okada S
    J Gastroenterol Hepatol; 1998 Aug; 13(8):825-9. PubMed ID: 9736177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for primary sclerosing cholangitis.
    Chazouillères O; Poupon R; Capron JP; Metman EH; Dhumeaux D; Amouretti M; Couzigou P; Labayle D; Trinchet JC
    J Hepatol; 1990 Jul; 11(1):120-3. PubMed ID: 1975818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
    Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
    Deneau MR; Mack C; Abdou R; Amin M; Amir A; Auth M; Bazerbachi F; Marie Broderick A; Chan A; DiGuglielmo M; El-Matary W; El-Youssef M; Ferrari F; Furuya KN; Gottrand F; Gupta N; Homan M; Jensen MK; Kamath BM; Mo Kim K; Kolho KL; Konidari A; Koot B; Iorio R; Martinez M; Mohan P; Palle S; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Valentino PL; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Miloh T
    Hepatol Commun; 2018 Nov; 2(11):1369-1378. PubMed ID: 30411083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
    Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
    Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.
    van Hoogstraten HJ; Wolfhagen FH; van de Meeberg PC; Kuiper H; Nix GA; Becx MC; Hoek AC; van Houte DP; Rijk MC; Salemans JM; Scherpenisse J; Schrijver M; Smit AM; Spoelstra P; Stadhouders PH; Tan TG; Hop WC; ten Kate FJ; vanBerge-Henegouwen GP; Schalm SW; van Buuren HR
    J Hepatol; 1998 Sep; 29(3):417-23. PubMed ID: 9764988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?
    van Milligen de Wit AW; Kuiper H; Camoglio L; van Bracht J; Jones EA; Tytgat GN; van Deventer SJ
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):129-36. PubMed ID: 10102223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC.
    Trauner M; Bowlus CL; Gulamhusein A; Hameed B; Caldwell SH; Shiffman ML; Landis C; Muir AJ; Billin A; Xu J; Liu X; Lu X; Chung C; Myers RP; Kowdley KV
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1552-1560.e2. PubMed ID: 35934287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
    Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G
    Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
    Assis DN; Abdelghany O; Cai SY; Gossard AA; Eaton JE; Keach JC; Deng Y; Setchell KD; Ciarleglio M; Lindor KD; Boyer JL
    J Clin Gastroenterol; 2017 Feb; 51(2):e11-e16. PubMed ID: 27428727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study.
    Rahimpour S; Nasiri-Toosi M; Khalili H; Ebrahimi-Daryani N; Nouri-Taromlou MK; Azizi Z
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):457-464. PubMed ID: 27981301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
    Fracchia M; Soubrane O; Houssin D; Galatola G
    Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
    Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group.
    Lindor KD
    N Engl J Med; 1997 Mar; 336(10):691-5. PubMed ID: 9041099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
    Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
    Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.